Has Chen Huang received payments from drug or device companies?

Yes. Drug and device makers reported $4,648 in general payments to Chen Huang across 182 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chen Huang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chen Huang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chen Huang

Medical Oncology · Harrison, ARNPI 1184720807

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,295 of the $4,648 with a category attached, or 70.9%. It is spread thinly across 44 manufacturers, the largest accounting for just 21.6%. Reporting peaked in 2024 at $2,073 and has fallen 78.2% since, to $452 in 2025.

$4,648in general payments, 2019–2025

Across 182 payments — averaging $25.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1K
AstraZeneca$458
Seagen Inc.$306
Sobi, Inc$264
Astellas Pharma US Inc$263
Incyte Corporation$242
plus $2K from 38 others

What the payments were for

Food & beverage$3,29571%
Education$53812%
Other$81518%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	20	$1,002
AstraZeneca(2 entities)	16	$458
Seagen Inc.	8	$306
Sobi, Inc	14	$264
Astellas Pharma US Inc	7	$263
Incyte Corporation	13	$242
Bayer	10	$186
AbbVie	10	$180
Johnson & Johnson	8	$169
Bristol Myers Squibb	9	$160
Merck	7	$137
E.r. Squibb & Sons, L.L.C.	4	$124
AVEO Pharmaceuticals, Inc.	2	$107
Regeneron Healthcare Solutions, Inc.	5	$91
Daiichi Sankyo Inc.	5	$88
Pfizer	4	$77
Amgen	3	$55
Exelixis Inc.	3	$49
Genmab U.S., Inc.	2	$46
Pharmacyclics LLC, An Abbvie Company	2	$46
Stemline Therapeutics Inc.	2	$44
Blueprint Medicines Corporation	2	$39
Progenics Pharmaceuticals, Inc.	2	$39
Rigel Pharmaceuticals, Inc.	2	$37
Gilead	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$36
EMD Serono, Inc.	1	$35
Beigene USA, Inc.	1	$26
Jazz Pharmaceuticals Inc.	1	$25
Genentech USA, Inc.	1	$25
Coherus Oncology, Inc.	1	$24
Eisai Inc.	1	$24
Caris MPI, Inc.	1	$21
Sumitomo Pharma America, Inc.	1	$19
Pharmaessentia USA Corporation	1	$19
Servier Pharmaceuticals LLC	1	$19
Morphosys, US Inc.	1	$18
Novo Nordisk	1	$18
Pharmacosmos Therapeutics Inc.	1	$17
Menarini Silicon Biosystems, Inc.	1	$17
Ipsen Biopharmaceuticals, Inc	1	$17
Beone Medicines USA, Inc.	1	$17
GSK	1	$16
Sanofi	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IMFINZI$125

How this compares

$4,648 in reported general payments places this provider in the 60th percentile of 20 medical oncology providers in Arkansas.

See all medical oncology providers in Arkansas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azithromycin	14	$169
Levothyroxine Sodium	23	$129
Metoclopramide Hcl	15	$57
Prednisone	15	$43

Paid to pharmacies, not to this prescriber.

Other medical oncology in Harrison

Muthu KumaranLittle Rock$193K
Sunilkumar KakadiaHot Springs$31K
Cesar Gentille SanchezLittle Rock$29K
Stephen ToothakerSearcy$19K
Ryan KochSearcy$15K
Zaki SammanFort Smith$9K
Kristen SagerMena$8K
William RobertsonSearcy$4K
Marc MonteJonesboro$2K
Shadiqul HoqueNorth Little Rock$1K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →